Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The primary objective is to explore the safety of low doses of oral levosimendan in patients
with recent history of an ischaemic cerebrovascular event (stroke or TIA). The main focus
will be on the evaluation of proarrhythmic potential of the different dose regimens.